回盛生物 - Financials

回盛生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016
+Revenue	1.2B	1.0B	1.0B	996.0M	777.0M	427.0M	422.0M	400.0M	258.0M
Revenue Growth %	17.6%	-0.3%	2.7%	28.2%	82.0%	1.2%	5.5%	55.0%	--
Total Revenue	1.2B	1.0B	1.0B	996.0M	777.0M	427.0M	422.0M	400.0M	258.0M
Cost Of Revenue	1.0B	806.0M	798.0M	725.0M	490.0M	264.0M	238.0M	197.0M	122.0M
+Gross Profit	196.0M	214.0M	225.0M	271.0M	287.0M	163.0M	184.0M	203.0M	136.0M
Gross Margin %	16.3%	21.0%	22.0%	27.2%	36.9%	38.2%	43.6%	50.7%	52.7%
Total Operating Cost	1.2B	1.0B	976.0M	856.0M	612.0M	356.0M	345.0M	299.0M	203.0M
Selling Expenses	59.3M	55.6M	48.4M	47.2M	52.6M	38.8M	46.7M	57.9M	49.2M
Admin Expenses	59.5M	75.7M	54.0M	41.9M	34.4M	23.8M	20.5M	19.1M	15.4M
Rd Expenses	55.8M	44.6M	40.1M	46.9M	28.4M	21.1M	20.4M	18.0M	12.8M
Finance Expenses	40.5M	24.4M	14.1M	-4.4M	-3.9M	1.5M	1.1M	-98,200	155,300
+Operating Income	-29.1M	15.1M	59.2M	151.0M	177.0M	78.6M	81.5M	103.0M	54.5M
Operating Margin %	-2.4%	1.5%	5.8%	15.2%	22.8%	18.4%	19.3%	25.8%	21.1%
Non Operating Income	390,000	208,700	94,800	175,500	81,400	415,900	625,600	506,200	4.3M
Non Operating Expenses	278,300	2.9M	2.5M	371,000	566,300	369,500	447,900	162,200	602,500
Investment Income	8.2M	13.1M	5.5M	2.9M	215,100	--	--	-45,000	--
Fair Value Change Income	-23.6M	12.3M	1.5M	1.5M	633,200	--	--	--	--
Asset Disposal Income	--	--	6,900	--	--	-10,300	-9,700	-286,700	-246,100
Asset Impairment Loss	1.3M	2.6M	2.1M	1.6M	970,500	1.0M	12.9M	1.9M	804,100
Other Income	16.5M	14.1M	5.4M	6.3M	9.9M	7.2M	4.3M	3.0M	--
Income Before Tax	-29.0M	12.4M	56.7M	151.0M	176.0M	78.6M	81.7M	104.0M	58.2M
Income Tax	-9.2M	-4.3M	4.0M	18.0M	25.9M	9.8M	10.3M	15.3M	8.8M
+Net Income	-19.8M	16.8M	52.7M	133.0M	150.0M	68.8M	71.4M	88.4M	49.4M
Net Margin %	-1.6%	1.6%	5.2%	13.4%	19.3%	16.1%	16.9%	22.1%	19.1%
Net Income Attributable	-20.2M	16.8M	52.7M	133.0M	150.0M	68.8M	71.4M	88.4M	49.4M
Minority Interest	382,400	--	--	--	--	--	--	-14,800	-24,800
Eps Basic	-0.12	0.10	0.32	0.80	1.02	0.83	0.89	1.11	0.65
Eps Diluted	-0.12	0.10	0.32	0.80	1.02	0.83	0.89	1.11	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016
Cash And Equivalents	326.0M	294.0M	424.0M	1.1B	345.0M	104.0M	99.5M	53.4M	52.3M
Trading Financial Assets	201.0M	304.0M	362.0M	30.2M	241.0M	--	--	--	--
Accounts Receivable	368.0M	319.0M	338.0M	232.0M	202.0M	98.2M	77.4M	40.4M	26.6M
Notes Receivable	61.8M	10.1M	10.0M	8.4M	29.0M	5.3M	11.5M	3.0M	1.2M
Notes And Accounts Receivable	430.0M	329.0M	348.0M	240.0M	231.0M	103.0M	89.0M	43.4M	27.8M
Prepayments	71.0M	62.3M	8.5M	8.9M	24.0M	6.7M	3.2M	20.5M	6.7M
Inventory	248.0M	229.0M	199.0M	232.0M	127.0M	72.4M	82.3M	57.9M	48.0M
Total Current Assets	1.3B	1.3B	1.4B	1.6B	1.2B	293.0M	276.0M	178.0M	137.0M
Fixed Assets	--	1.5B	1.2B	534.0M	145.0M	150.0M	93.2M	97.2M	--
Fixed Assets Total	1.5B	1.5B	1.2B	534.0M	145.0M	150.0M	93.2M	97.2M	83.2M
Construction In Progress	--	53.1M	333.0M	473.0M	267.0M	83.1M	21.2M	1.3M	--
Construction In Progress Total	18.1M	53.1M	333.0M	473.0M	267.0M	83.1M	21.2M	1.3M	5.1M
Intangible Assets	114.0M	104.0M	107.0M	110.0M	95.8M	98.2M	63.6M	65.1M	28.3M
Long Term Deferred Expenses	1.9M	2.7M	371,700	--	--	--	317,900	1.3M	493,600
Total Non Current Assets	1.7B	1.7B	1.6B	1.1B	575.0M	358.0M	191.0M	166.0M	119.0M
Total Assets	3.0B	3.0B	3.0B	2.7B	1.8B	650.0M	467.0M	344.0M	256.0M
Short Term Borrowings	317.0M	240.0M	220.0M	100.0M	63.0M	29.0M	25.0M	--	--
Accounts Payable	223.0M	318.0M	310.0M	136.0M	79.8M	73.3M	27.0M	17.9M	22.6M
Advance Receipts	10,200	--	--	--	--	7.0M	6.8M	16.7M	10.1M
Contract Liabilities	13.5M	10.3M	15.6M	13.9M	13.3M	--	--	--	--
Total Current Liabilities	923.0M	781.0M	805.0M	503.0M	339.0M	204.0M	139.0M	118.0M	98.0M
Long Term Borrowings	59.1M	--	--	35.2M	--	33.7M	--	--	--
Total Non Current Liabilities	626.0M	685.0M	643.0M	620.0M	34.4M	68.0M	3.2M	3.0M	3.2M
Total Liabilities	1.5B	1.5B	1.4B	1.1B	373.0M	272.0M	142.0M	121.0M	101.0M
Paid In Capital	166.0M	166.0M	166.0M	166.0M	111.0M	82.8M	82.8M	80.0M	80.0M
Capital Reserve	881.0M	874.0M	877.0M	882.0M	927.0M	104.0M	104.0M	56.7M	56.7M
Surplus Reserve	53.0M	53.0M	50.9M	47.5M	30.1M	18.9M	14.3M	9.2M	2.2M
Retained Earnings	277.0M	342.0M	376.0M	382.0M	312.0M	173.0M	124.0M	77.2M	15.8M
Minority Equity	7.6M	--	--	--	--	--	--	--	11,300
Equity Attributable	1.5B	1.5B	1.5B	1.6B	1.4B	378.0M	325.0M	223.0M	155.0M
Total Equity	1.5B	1.5B	1.5B	1.6B	1.4B	378.0M	325.0M	223.0M	155.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016
Cash From Sales	993.0M	1.0B	1.0B	1.0B	704.0M	426.0M	381.0M	429.0M	289.0M
Tax Refunds Received	2.9M	1.2M	32.9M	43.4M	3.2M	332,300	479,800	--	--
Total Operating Cash Inflow	1.0B	1.1B	1.1B	1.2B	735.0M	461.0M	402.0M	438.0M	297.0M
Cash Paid For Goods	717.0M	737.0M	808.0M	788.0M	525.0M	222.0M	233.0M	215.0M	136.0M
Cash Paid To Employees	136.0M	135.0M	106.0M	105.0M	62.0M	54.8M	60.4M	57.9M	40.6M
Taxes Paid	43.1M	42.4M	33.0M	45.0M	44.3M	31.6M	40.0M	44.9M	26.9M
Total Operating Cash Outflow	984.0M	989.0M	1.0B	1.0B	687.0M	356.0M	381.0M	358.0M	237.0M
Operating Cash Flow	43.5M	92.9M	96.7M	156.0M	48.3M	105.0M	21.1M	80.6M	60.0M
Total Investing Cash Inflow	669.0M	1.1B	699.0M	625.0M	60.4M	113,900	38,400	235,600	1.4M
Total Investing Cash Outflow	771.0M	1.2B	1.4B	810.0M	731.0M	123.0M	34.1M	56.4M	29.3M
Investing Cash Flow	-102.0M	-100.0M	-750.0M	-185.0M	-670.0M	-123.0M	-34.0M	-56.2M	-27.9M
Cash From Borrowings	480.0M	211.0M	203.0M	135.0M	114.0M	80.0M	53.0M	13.5M	1.5M
Dividends And Interest Paid	59.2M	58.6M	62.5M	47.9M	6.0M	16.7M	21.6M	24.4M	19.8M
Debt Repayments	480.0M	244.0M	135.0M	63.0M	120.0M	36.1M	28.0M	13.5M	11.5M
Total Financing Cash Inflow	556.0M	265.0M	221.0M	836.0M	982.0M	80.0M	103.0M	13.5M	18.1M
Total Financing Cash Outflow	542.0M	306.0M	256.0M	126.0M	156.0M	58.1M	49.6M	37.9M	31.3M
Financing Cash Flow	14.0M	-41.5M	-34.6M	710.0M	826.0M	21.9M	53.4M	-24.4M	-13.2M
Net Change In Cash	-44.9M	-49.1M	-688.0M	681.0M	204.0M	4.2M	40.5M	-25,900	18.9M
Ending Cash Balance	185.0M	230.0M	279.0M	966.0M	286.0M	81.9M	77.7M	37.2M	37.3M
Capex	194.0M	184.0M	429.0M	600.0M	231.0M	123.0M	34.1M	56.4M	28.0M